Aoxing Pharmaceutical Stock Forecast, Price & News

Wall Street analysts have given Aoxing Pharmaceutical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aoxing Pharmaceutical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Aoxing Pharmaceutical saw a decrease in short interest in the month of August. As of August 13th, there was short interest totaling 200 shares, a decrease of 88.9% from the July 29th total of 1,800 shares. Based on an average trading volume of 14,300 shares, the days-to-cover ratio is presently 0.0 days.
View Aoxing Pharmaceutical's Short Interest.

Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) issued its quarterly earnings data on Monday, May, 16th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $6.56 million for the quarter.
View Aoxing Pharmaceutical's earnings history.

Aoxing Pharmaceutical's stock was trading at $0.0076 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AOXG shares have decreased by 38.2% and is now trading at $0.0047.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Aoxing Pharmaceutical include Endonovo Therapeutics (ENDVD), Achaogen (AKAOQ), Inspyr Therapeutics (NSPX), Boston Therapeutics (BTHE), FutureWorld (FWDG), Skinvisible (SKVI), HST Global (HSTC), Argos Therapeutics (ARGSQ), Cardax (CDXI), Cardax (CDXI), Targeted Medical Pharma (TRGM), Aeolus Pharmaceuticals (AOLS), Propanc Biopharma (PPCB), Spotlight Innovation (STLT) and Sophiris Bio (SPHS).
View all of AOXG's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), Spark Networks (LOV), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC), Edap Tms (EDAP), Fortress Biotech (FBIO), Inovio Pharmaceuticals (INO) and Pernix Therapeutics (PTX).

Aoxing Pharmaceutical trades on the OTCMKTS under the ticker symbol "AOXG."

Shares of AOXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AOXG stock can currently be purchased for approximately $0.00.

Aoxing Pharmaceutical has a market capitalization of $328,154.00.

Aoxing Pharmaceutical employs 346 workers across the globe.

The official website for Aoxing Pharmaceutical is axzyen.icm.cn.

Aoxing Pharmaceutical is headquartered at FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE, SHIJIAZHUANG CITY F4, 94404.

Aoxing Pharmaceutical's mailing address is FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE, SHIJIAZHUANG CITY F4, 94404. The company can be reached via phone at (646) 367-1749 or via email at [email protected]